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Abstract
Aim Women with prior gestational diabetes (GDM) are at increased diabetes risk. This study aimed to assess whether life-
style is associated with glycemic health of high-risk women 5 years postpartum, taking into account the pre-pregnancy BMI.
Methods The RADIEL study enrolled before or in early pregnancy 720 women with pre-pregnancy BMI ≥ 30 kg/m2 and/or 
prior GDM. The follow-up visit 5 years postpartum included questionnaires and measurements of anthropometrics, blood 
pressure, and physical activity (PA) as well as analyses of glucose metabolism, lipids, and inflammatory markers. We meas-
ured body composition (Inbody) and calculated a Healthy Food Intake Index (HFII) from Food Frequency Questionnaires 
(FFQ). ArmBand measured PA, sedentary time, and sleep. To take into account the diverse risk groups of GDM, we divided 
the women based on pre-pregnancy BMI over/under 30 kg/m2.
Results Altogether 348 women attended the follow-up. The obese and non-obese women showed similar prevalence of 
glycemic abnormalities, 13% and 19% (p = 0.139). PA levels were higher among the non-obese women (p < 0.05), except 
for step count, and their HFII was higher compared to the obese women (p = 0.033). After adjusting for age, education, and 
GDM history, PA and HFII were associated with glycemic health only among obese women. When both lifestyle factors 
were in the same model, only PA remained significant. PA associated with other markers of metabolic health also among 
the non-obese women, excluding HbA1c.
Conclusion Lifestyle 5 years postpartum was associated with better glycemic health only among the obese high-risk women. 
PA, however, is essential for the metabolic health of all high-risk women.
Clinical trial registration ClinicalTrials.gov, http://www.clini caltr ials.com, NCT01698385.
Keywords Gestational diabetes · Heterogeneity · Type 2 diabetes · Physical activity · Diet
Introduction
The escalating epidemic of obesity and diabetes [1] requires 
efficient methods for prevention. Fortunately, according 
to large international studies, type 2 diabetes (T2D) is This article belongs to the topical collection Pregnancy and 
Diabetes, managed by Antonio Secchi and Marina Scavini.
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preventable among high-risk groups with lifestyle interven-
tion [2, 3]. Women with a history of gestational diabetes 
(GDM) are at a sevenfold risk of developing future diabetes 
[4, 5] and therefore many intervention studies have recently 
focused also on women with prior GDM [6]. For example, 
the RADIEL (The Finnish Gestational Diabetes Prevention) 
lifestyle intervention starting during pregnancy and continu-
ing during the 1st postpartum year successfully reduced the 
incidence of glycemic abnormalities 1 year after delivery 
[7].
T2D and GDM, however, are heterogeneous diseases. 
Scandinavian researchers recently categorized T2D into 5 
subclasses [8], each with varying characteristics, compli-
cations, and progression. The heterogeneity of GDM has 
received less interest, but in addition to T2D, also women 
with GDM differ by their body composition, insulin secre-
tion and resistance, as well as diabetes-related autoimmunity 
[9–12]. In the RADIEL study, the incidence of glycemic 
abnormalities was high 5 years postpartum also among the 
non-obese women with prior GDM, and they presented often 
with normal-weight obesity (NWO), i.e., normal body mass 
index (BMI) but high body fat percentage [13].
There are suggestions that physical inactivity, smok-
ing, alcohol consumption, and poorer dietary habits of 
NWO individuals could explain their impaired metabolic 
health [14]. This could offer one possible explanation for 
the high prevalence of glycemic abnormalities postpartum 
also among the non-obese GDM women. On the other hand, 
non-obese women with GDM have typically a deficiency 
in insulin production [15] and we hypothesize that lifestyle 
changes aiming at reducing insulin resistance by increasing 
physical activity (PA) and improving diet quality might not 
have similar effect among non-obese and obese women. The 
aim of this study was to assess the lifestyle of women at 
high risk for diabetes 5 years postpartum and to evaluate the 
associations between lifestyle and glycemic health in GDM 
subgroups, i.e., obese and non-obese women based on their 
pre-pregnancy BMI over/under 30 kg/m2.
Materials and methods
Study design
This is a cross-sectional study focusing on the partici-
pants of the RADIEL 5-year follow-up study. Originally, 
the RADIEL lifestyle intervention study was a randomized 
controlled trial (RCT), recruiting women at high risk for 
GDM before or in early pregnancy. Altogether 724 women 
entered the study between years 2008–2014. During years 
2013–2017, 5 years after delivery, all participants with a live 
birth and their children were invited to a follow-up study. 
In the original study, some participants visited the study 
nurse for data collection every 3 months before pregnancy 
and all participants once in each trimester of pregnancy 
and 6 weeks, 6 and 12 months postpartum. The study visits 
took place in Helsinki, in the Helsinki University Hospital 
(HUH), and in Lappeenranta, in South Karelian Central Hos-
pital (SKCH). Previous publications provide the details of 
these studies [13, 16].
The study participants were at least 18 years of age and 
had a BMI 30 kg/m2 or over, and/or prior GDM. Overt dia-
betes, medications altering glucose metabolism, multiple 
pregnancy, severe psychiatric problems, physical disabili-
ties, and communication problems based on inadequate lan-
guage skills led to exclusion. All participants gave a written 
informed consent and the ethics committees of the HUH and 
SKCH both approved the study protocol.
Outcomes
The main outcome of this study is the presence of glyce-
mic abnormalities 5 years after delivery. All participants, 
except for those with physician-diagnosed T2D or prior 
bariatric surgery, underwent a 75 g 2-h oral glucose tol-
erance test (OGTT). T2D diagnosis was based on fasting 
plasma glucose ≥ 7.0 mmol/l or 2-h glucose ≥ 11.1 mmol/l. 
The definition for impaired glucose tolerance (IGT) was 2-h 
glucose 7.8–11.0 mmol/l and diagnosis of impaired fasting 
glucose (IFG) required fasting plasma glucose in the range 
of 6.1–6.9 mmol/l. Completing the criteria of either IFG, 
IGT, or T2D resulted in a composite outcome of glycemic 
abnormality.
Each study visit included measurements of body weight, 
height, and waist and hip circumference. The calculation 
for postpartum weight change derived from the difference 
between weight at the study visits 6 weeks and 5 years 
postpartum. Blood pressure was measured with a sphyg-
momanometer in a sitting position from the right arm. The 
laboratory tests in conjunction with the study visit, after a 
10–12 h fast, included analysis of glucose metabolism (2 h 
75 g OGTT, GHbA1c, insulin), lipids (cholesterol, low-den-
sity lipoprotein cholesterol LDL, high-density lipoprotein 
cholesterol HDL, and triglycerides), inflammatory markers 
(highly sensitive C-reactive protein hs-CRP), and alanine 
amino transferase (ALAT). A multi-frequency bio-imped-
ance measurement method (InBody3.0, Biospace Co., Ltd, 
Seoul, Korea) provided the information on body composi-
tion [17]. AGE Reader measured the advanced-glycation 
end-products (AGEs), which are potential early markers of 
diabetes risk.
Lifestyle in this study refers to PA and diet. SenseWear 
ArmBand Pro 3 recorded PA, sedentary time, and sleep of 
the participants, who wore the monitor in their upper non-
dominant arm. The monitor required removal while shower-
ing, sauna, and water-sports. To be included in the analysis, 
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we required recording of at least 85% of a day, during a 
minimum of 4 days, and including at least one weekend day. 
We extracted measures for light PA (LPA) (min/day), moder-
ate-to-vigorous PA (MVPA) (min/day), vigorous PA (VPA) 
(min/day), sleep (h/day), steps (counts/day), and sedentary 
time (min/day, excluding sleep).
Food frequency questionnaires (FFQ) provided the infor-
mation on current diet. In the analysis, we used the daily 
intake of specified food groups as well as a healthy food 
intake index (HFII) describing the diet as an entity; partici-
pants received points reflecting their intake of high-energy/
low-nutrient snacks (0–2 points), sugar-sweetened beverages 
(0–1 points), fast food (0–1 points), high-fiber grains (0–2 
points), bread fat spread (0–2 points), low-fat cheese (0–1 
points), low-fat milk (0–2 points), fish (0–2 points), red and 
processed meat (0–2 points), vegetables (0–2 points), and 
fruits and berries (0–1 points). The maximum score availa-
ble was 18, with a higher score indicating a healthier diet. In 
case of a missing answer, the HFII score was not calculated. 
We used HFII both as continuous and as categorical, divided 
into three categories. The first cut-off was determined by 
subtracting 1SD from the mean and the second by adding 
1SD to the mean.
Background questionnaires covered additional aspects 
of lifestyle, such as smoking, with regular and occasional 
smoking combined. Questionnaires also recorded self-
reported duration of breastfeeding, years of education, 
family income as well as chronic illnesses. The Center for 
Epidemiological Studies Depression Scale (CES-D) [18] 
provided the tool for assessing depressive symptoms. In the 
analysis we used both the logarithmic sum as a continuous 
variable and the generally acknowledged cut-off of 16 points 
to indicate depression [19].
For assessing the associations between lifestyle and gly-
cemic health, we divided the women based on their pre-
pregnancy BMI over or under 30 kg/m2. The justification 
for using pre-pregnancy instead of current BMI was the high 
metabolic risk of the normal-weight women with GDM [20]. 
The postpartum weight change in either direction could have 
mixed these diverse risk groups which potentially have dif-
ferent pathophysiological backgrounds. When referring to 
subgroups based on BMI (non-obese and obese) in this arti-
cle, we always refer to the pre-pregnancy BMI.
Statistics
We examined normal distribution of the variables with the 
Shapiro–Wilk test. Descriptive characteristics are presented 
as means with standard deviations (SD), medians with inter-
quartile range (IQR) or as frequencies with percentages. 
Between-groups comparisons were performed with the Chi 
square test, the Mann–Whitney U test, ANOVA, or the inde-
pendent sample T test, when appropriate. For examining the 
associations between glycemic abnormalities and lifestyle 
(MVPA and HFII) we used the binary logistic regression 
model. We assessed the correlations between PA and meta-
bolic characteristics with Spearman’s rank-order correlation. 
We performed the statistical analyses with the SPSS 24.0 
software program (SPSS Inc., Chicago, IL, USA) and con-
sidered a p value < 0.05 as statistically significant.
Results
Data on glucose metabolism were available for 348 women, 
HFII for 298 women, and device-measured PA for 206 
women. In total 51 women (13.6%) had a glycemic abnor-
mality; 24 women (6.4%) had IFG, 24 women (6.4%) IGT, 
and 13 women (3.5%) T2D.
At the follow-up visit, previously obese and non-obese 
women differed significantly in most measured parameters 
(Table 1). In addition to better metabolic health, non-obese 
women also showed lower depression scores. There were 
no differences in age, smoking, family history of diabetes, 
or GHbA1c between the BMI-groups. Among the obese 
women, 7 (3.1%) were diagnosed with T2D, 16 (7.2%) had 
IGT, and 13 women (5.8%) IFG. The corresponding num-
bers for non-obese women were 6 (4.8%), 8 (6.4%) and 11 
(8.8%), respectively. There was no statistically significant 
difference in the prevalence of IFG, IGT, or T2D between 
the groups. The indices for insulin resistance (HOMA-IR) 
and insulin secretion (HOMA-β) were significantly differ-
ent: previously obese women showed higher HOMA-IR and 
HOMA-β levels.
Table 2 presents the lifestyle measurements 5 years after 
delivery. The non-obese women slept more, had less seden-
tary time, and higher PA levels, except for the step count, 
which did not differ between the groups. They also reported 
to consume less often snacks (p = 0.043) and more often 
high-fiber grains (p = 0.011), and also their HFII was statis-
tically significantly higher indicating a healthier diet com-
pared to the obese women (p = 0.033).
In the total study population, there was a detectable asso-
ciation between glycemic abnormalities and age [crude OR 
1.120 (1.044, 1.201) p = 0.002], years of education [crude 
OR 0.667 (0.449, 0.990) p = 0.044], body fat percentage 
[crude OR 1.044 (1.066, 1.085) p = 0.025], postpartum 
weight change [crude OR 1.055 (1.020, 1.090) p = 0.002], 
GDM history [crude OR 5.181 (1.998, 13.435) p = 0.001] 
and current BMI [crude OR 1.058 (1.012, 1.107) p = 0.012]. 
There was no association between glycemic abnormalities 
and RADIEL lifestyle intervention, depression, breastfeed-
ing, diet, physical activity, sleep, or family income. Based 
on these results, we adjusted the further logistic regres-
sion models with GDM history, age, and education years. 
Body fat percentage and postpartum weight change were 
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not included, as they can be considered as mediators of the 
lifestyle effects.
There was an interaction between pre-pregnancy BMI 
and MVPA (p = 0.009) on glycemic abnormalities (Fig. 1), 
but not between pre-pregnancy BMI and diet. Table 3 pre-
sents the multivariable regression models among obese and 
non-obese women. Lifestyle was associated with glycemic 
health only among women with pre-pregnancy BMI 30 kg/
m2 or higher; after adjusting with age, education, and GDM 
history, both MVPA and HFII were associated with glyce-
mic health. When adjusted additionally with current BMI 
and analyzing both lifestyle factors in the same model, only 
PA remained significant. When performing the regression 
analysis with HFII as a categorical variable the results were 
similar (data not shown).
To further assess the importance of PA in phenotypically 
diverse groups, we evaluated the correlations between meas-
ures of PA, sedentary time, and sleep and markers of meta-
bolic health. Table 4 presents these correlations, adjusted 
with age, education years, and GDM history, separately 
among obese and non-obese women. Among obese women, 
VPA, MVPA, LPA, and sedentary time correlated with all 
markers of metabolic health. Step count correlated with 
body fat percentage, HDL, insulin, and blood pressure. 
Among non-obese women VPA and MVPA correlated with 
all other markers of metabolic health, except for GHbA1c.
Discussion
The association between lifestyle and glycemic health var-
ies between obese and non-obese high-risk women. In our 
study, the non-obese women were physically more active 
and had a healthier diet compared to obese women. Despite 
their healthier lifestyle, however, they presented with similar 
prevalence of glycemic abnormalities 5 years postpartum. 
When adjusted for age, education, and GDM history, PA 
and diet were associated with better glycemic health only 
among the obese women. This remained significant even 
when adjusted with current BMI. However, higher levels of 
Table 1  Characteristics 5 years postpartum, in subgroups of obese and non-obese participants based on the pre-pregnancy BMI > 30 kg/m2
Data are presented as means (SD), medians (IQR), or frequencies (%)
a Comparing obese and non-obese women. Results from Independent samples t test, Mann–Whitney U test, or Chi Square accordingly








BMI (kg/m2) 31.7 (6.7) 35.2 (5.3) 25.5 (3.6) < 0.001
Age (years) 38.6 (4.6) 38.4 (4.8) 39.0 (4.2) 0.249
Family history of diabetes (n, %) 108 (32) 63 (29) 45 (36) 0.201
Body fat percentage 39.7 (32.9, 46.1) 43.9 (39.1, 48.4) 32.1 (26.1, 36.1) < 0.001
GDM history (n, %)b 236 (68) 111 (50) 125 (100) < 0.001
AGE value 1.80 (1.60, 1.90) 1.80 (1.60, 1.95) 1.80 (1.55, 1.90) 0.758
Smoking (n, %) 48 (14) 32 (15) 16 (13) 0.749
Depression (log sum CES-D) (n = 179 + 94) 2.3 (1.8, 2.8) 2.4 (1.8, 2.9) 2.1 (1.4, 2.6) 0.033
Depression (CES-D > 16) (n, %)
(n = 179 + 94)
75 (27.5) 55 (30.7) 20 (21.3) 0.097
Waist circumference (cm) 105 (16) 113 (14) 91 (11) < 0.001
Hip circumference (cm) 112 (13) 118 (11) 101 (8) < 0.001
RR systolic (mmHg) 125 (14) 129 (15) 118 (11) < 0.001
RR diastolic (mmHg) 79 (10) 81 (11) 75 (8) < 0.001
Total cholesterol (mmol/l) 4.7 (0.8) 4.6 (0.8) 4.8 (0.7) 0.085
HDL cholesterol (mmol/l) 1.5 (0.4) 1.4 (0.3) 1.6 (0.3) < 0.001
LDL cholesterol (mmol/l) 3.0 (0.8) 3.0 (0.8) 3.0 (0.7) 0.812
Triglycerides (mmol/l) 0.9 (0.7, 1.2) 0.9 (0.7, 1.4) 0.8 (0.6, 1.0) < 0.001
GHbA1c (%) 5.4 (0.5) 5.4 (0.6) 5.4 (0.5) 0.982
Fasting plasma insulin (mU/l) 9.3 (6.3, 14.4) 11.3 (7.5, 15.9) 6.7 (5.0, 9.6) < 0.001
HOMA-IR 2.2 (1.4, 3.3) 2.7 (1.6, 3.6) 1.6 (1.1, 2.3) < 0.001
HOMA-β (%) 116.2 (76.4, 178.8) 140.0 (96.5, 200.0) 76.7 (61.6, 116.7) < 0.001
hs-CRP (mg/l) 1.4 (0.6, 3.3) 2.0 (1.0, 4.4) 0.6 (0.4, 1.5) < 0.001
Postpartum weight change (%) 2.2 (− 5.1, 8.1) 5.1 (− 2.7, 10.2) − 0.1 (− 6.4, 4.8) < 0.001
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MVPA and VPA were associated with numerous other com-
ponents of metabolic health, such as lower body fat percent-
age, blood pressure, and healthier lipid profile, also among 
the non-obese high-risk women.
Although previous studies have suggested that NWO indi-
viduals might have poorer dietary habits, this was not true in 
our population. The non-obese women had overall a higher 
HFII indicating a healthier diet compared to obese partici-
pants. They also consumed less snacks and more whole grain 
products, which have been suspected to improve the func-
tion of beta cells [21], and there was a trend toward lower 
consumption of red meats, generally associated with lower 
diabetes risk [22]. The HFII of non-obese women, however, 
was not associated with glycemic health 5 years postpartum.
The non-obese participants were also physically more 
active. PA is generally associated with lower morbidity and 
mortality [23] and device-measured PA has shown even a 
stronger association with health benefits [24]. The influence 
of PA may be at least partly mediated through reductions in 
total and abdominal fat leading to improvements in insulin 
sensitivity and blood pressure, and possibly improvements 
in endothelial vascular function [25]. Our results are in line 
with previous studies as PA was associated with blood pres-
sure, body fat percentage, lipids, waist circumference, insu-
lin, and hs-CRP among all participants.
In our study there was, however, a significant interaction 
between PA and pre-pregnancy BMI when assessing glyce-
mic abnormalities. Also a few other studies have assessed the 
influence of lifestyle in phenotypically different subgroups. 
An Indian study demonstrated that weight loss is beneficial 
also among non-obese individuals with family history of 
diabetes [26]. In preventing the metabolic syndrome (MetS), 
PA seems similarly effective among non-obese individuals 
[27], which has been demonstrated also elsewhere [28].
Nevertheless, there are studies reporting similar inter-
actions in general population as in our study. In two large 
cohort studies, PA was associated with less visceral adipose 
tissue but this association attenuated after adjustment for 
BMI (32) and also the association between PA and BMI 
appeared weaker among non-obese individuals [29]. A study 
on 1109 adults, using accelerometer-measured PA, also 
demonstrated an interaction between BMI and association 
of MVPA and HbA1c [30].
On the other hand, the correlations between PA and 
metabolic parameters were similar among the obese and 
non-obese. The strongest correlation was with body fat 
percentage, waist circumference, and blood pressure. This 
is reassuring as lifestyle may influence the important car-
diovascular risk factors also among the non-obese, which 
has been reported also previously [31]. In our study, among 
non-obese women, however, associations existed only with 
more strenuous PA whereas even lower intensity PA was 
associated with better metabolic outcome among the obese. 
These results additionally supported our findings concerning 
glycemic abnormalities, as HbA1c and PA were not corre-
lated among non-obese women.
Table 2  Lifestyle 5 years 
postpartum among previously 
non-obese and obese women
Physical activity, sedentary time, and sleep were measured with SenseWear Armband and diet index and 
intakes of specific food groups were calculated from FFQs
Data are presented as medians (IQR)
FFQ food frequency questionnaire, LPA light physical activity, MVPA moderate-to-vigorous physical activ-
ity, VPA vigorous physical activity, HFII healthy food intake index, maximum score 18
Lifestyle Non-obese women Obese women p value
Physical activity (n) 80 126
Sleep (h/day) 7.1 (6.5, 7.5) 6.7 (6.1, 7.3) 0.006
Sedentary time (min/day) 555 (500, 631) 658 (575, 750) < 0.001
LPA (min/day) 269 (239, 330) 249 (181, 320) 0.024
MVPA (min/day) 89 (65, 124) 51 (34, 75) < 0.001
VPA (min/day) 1.5 (0.1, 6.6) 0.1 (0, 1.3) < 0.001
Steps (counts/day) 9316 (6623, 10,910) 8202 (6480, 10,287) 0.113
Diet (n) 108 190
HFII (points) 10 (8, 12) 9 (8, 11) 0.033
Red and processed meats (times/day) 1.42 (0.9, 2.3) 1.6 (1.1, 3.0) 0.055
Whole-grain cereals (times/day) 2.8 (1.5, 4.0) 2.2 (1.3, 3.5) 0.044
Vegetables and fruits (times/day) 7.1 (4.5, 9.7) 6.3 (4.4, 9.4) 0.722
Snacks (times/week) 0.9 (0.6, 1.5) 1.1 (0.7, 1.6) 0.043
Sugar-sweetened beverages (times/week) 0.1 (0, 0.1) 0.1 (0, 0.2) 0.961
Fish (times/week) 0.5 (0.4, 0.7) 0.5 (0.4, 0.7) 0.500
Fast food (times/week) 0.2 (0.1, 0.2) 0.2 (0.1, 0.2) 0.689
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A few reasons have been suggested to explain the het-
erogeneous response to lifestyle. Gene-lifestyle interactions 
may influence the susceptibility to weight gain and effective-
ness of lifestyle interventions [32, 33]. These interactions 
have been demonstrated in large studies, e.g., polymor-
phisms in the PPAR-gamma2 gene and Glu9 [33], as well 
as in the MTNR1B, which also decreased the effect of the 
RADIEL intervention in preventing GDM [34]. Polymor-
phisms in the PPAR-gamma2 gene, e.g., modify the effects 
of lifestyle on weight loss, lipids, and insulin sensitivity [33]. 
In the Finnish Diabetes Prevention Study certain polymor-
phisms in GHRL and LEPR genes modified the effect of PA 
on weight, waist circumference, lipids, and blood pressure, 
but had no effect on the progression from IGT to T2D [35]. 
Additionally, polymorphisms in the TNF-α gene may inter-
fere with the anti-inflammatory effect of PA [36].
In addition to genetic polymorphisms, also other back-
ground factors might interfere with the effects of lifestyle. 
It is estimated that 5–6% of GDM women have some form 
of monogenetic diabetes (MODY) [37, 38], which will not 
respond to lifestyle changes similarly. Lifestyle changes 
might also have a stronger effect among people with insulin 
resistance [39]. Hypothetically, the adiposity-related insulin 
resistance might be more reversible than the defects in insu-
lin secretion. In our study, the previously non-obese women 
showed significantly lower insulin secretion indices, gen-
erally associated with higher T2D risk [40]. Additionally, 
gut microbiota is known to influence the risk of developing 
diabetes in an interplay with diet [41].
Strengths of this study are the inclusion of phenotypi-
cally different groups of high-risk women. We also have 
detailed device-measured data on PA as well as detailed 
dietary information from FFQs and diet diaries. Addition-
ally, having measured multiple metabolic markers, including 
body composition, enables us to analyze not only glycemic 
disorders but also other aspects of metabolic health such as 
body fat percentage. Limitations of our study include the 
number of participants, especially when divided into sub-
groups, and lack of a control group to enable comparison 
with normal unselected population. Due to our study design, 
all non-obese participants had a history of GDM indicating a 
higher risk of glycemic abnormalities also postpartum. This 
might potentially influence our findings. Also, all partici-
pants were of Caucasian origin and this limits the generaliz-
ability of our findings.
Although intervention studies in big populations have 
reached well-documented positive results [6, 42], it is impor-
tant to assess components of lifestyle individually and in 
phenotypically distinct groups to further develop our rec-
ommendations for high-risk individuals. Our study demon-
strated that healthy lifestyle is essential for high-risk women, 
but among non-obese women it was not associated with bet-
ter glycemic health. PA, however, has a positive association 
with many other markers of metabolic health also among 
the non-obese, and is therefore most probably beneficial for 
their cardiovascular health.
We showed that higher levels of PA are associated with 
better metabolic health. However, other factors than life-
style may play a role for the glycemic health of non-obese 
women. It is important to recognize this high-risk group 
of non-obese women with prior GDM, as even their physi-
cally active lifestyle and healthier diet is not a marker of 
lower diabetes risk. Equally important is to study the fac-
tors behind their increased risk and to find new innovative 
ways to prevent T2D. There is a need for precision medi-
cine approach in diabetes research and treatment [8, 43] and 
studies focusing on genetic polymorphisms, microbiome, 
and metabolomics might provide new insights in the future. 
On the other hand, even more emphasis should be put on 
motivational lifestyle interventions among the obese women 
as T2D could be prevented. Perhaps individualized coun-
seling, social support, self-efficacy, and listening to women’s 
wishes [44] require further attention to improve the results 
Fig. 1  Moderate-to-vigorous  physical activity (MVPA min/day) in 
groups of previously non-obese and obese women, according to pres-
ence of glycemic abnormalities. Interaction p = 0.009. For the clar-
ity of the figure, two extremely high outliers were excluded from the 




Table 3  Logistic regression models demonstrating associations of physical activity and diet quality with glycemic abnormalities 5 years postpar-
tum in obese and non-obese women
HFII healthy food intake index, MVPA moderate-to-vigorous physical activity
(A) Logistic regression models adjusted with age, education, and GDM history













OR p OR p OR p OR p OR p OR p
MVPA 0.99 (0.98, 1.0) 0.18 0.96 
(0.93, 
0.99)
0.01 – – – – 0.99 (0.98, 1.0) 0.15 0.95 (0.91, 0.99) 0.02






0.04 1.07 (0.83, 1.38) 0.60 0.73 (0.53, 1.01) 0.05
(B) Logistic regression models adjusted with age, education, GDM history, and current BMI













OR p OR p OR p OR p OR p OR p





0.05 – – – – 0.996 (0.98, 1.01) 0.59 0.95 (0.91, 0.998) 0.04






0.05 1.16 (0.86, 1.57) 0.34 0.73 (0.53, 1.01) 0.06
Table 4  Correlations between markers of metabolic health and measures of physical activity, sleep, and sedentary time among subgroups of 
obese and non-obese women
Spearman’s rank-order correlations adjusted for age, education, and history of gestational diabetes
*p < 0.05
**p < 0.005
LPA light physical activity, MVPA moderate-to-vigorous physical activity, VPA vigorous physical activity
PA Body fat % Waist HbA1c hs-CRP HDL LDL Triglycerides Insulin Systolic RR Diastolic RR
rs rs rs rs rs rs rs rs rs rs
Obese
 Sleep − 0.27 − 0.109 − 0.092 − 0.062 0.115 − 0.048 − 0.095 − 0.047 0.001 0.036
 Steps − 0.200* − 0.055 − 0.140 − 0.122 0.254* − 0.136 − 0.123 − 0.187* − 0.233* − 0.239*
 Sedentary 0.515** 0.427** 0.269* 0.440** − 0.416** 0.272* − 0.316** 0.359** 0.339** 0.421**
 LPA − 0.437** − 0.357** − 0.198* − 0.399** 0.373** − 0.196* − 0.194* − 0.302* − 0.384** − 0.473**
 MVPA − 0.437** − 0.332** − 0.204* − 0.343** 0.240** − 0.209* − 0.287* − 0.382** − 0.269* − 0.299*
 VPA − 0.496** − 0.461** − 0.261* − 0.486** 0.399** − 0.100 − 0.413** − 0.545** − 0.200* − 0.276*
Non-obese
 Sleep 0.168 0.022 − 0.175 0.025 0.011 0.100 0.144 0.127 − 0.109 − 0.051
 Steps − 0.324* − 0.227* 0.162 − 0.184 0.135 − 0.243* − 0.232* − 0.279* 0.054 − 0.042
 Sedentary 0.300* 0.320* − 0.046 0.223 − 0.273* 0.206 0.111 0.106 0.092 0.102
 LPA 0.161 0.162 0.056 − 0.007 0.046 − 0.033 0.012 − 0.010 0.198 0.075
 MVPA − 0.673** − 0.637** − 0.027 − 0.445** 0.322* − 0.255* − 0.289* − 0.397** − 0.320* − 0.195
 VPA − 0.577** − 0.473** 0.123 − 0.341* 0.224* − 0.235* − 0.415** − 0.561** − 0.217* − 0.238*
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of lifestyle interventions [45]. As T2D is an expanding epi-
demic, we cannot afford to neglect this group of high-risk 
women.
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